Page last updated: 2024-11-07

norethindrone acetate and Bonnevie-Ullrich Syndrome

norethindrone acetate has been researched along with Bonnevie-Ullrich Syndrome in 1 studies

norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.

Bonnevie-Ullrich Syndrome: This syndrome that was originally observed by Ullrich, and designated as identical to TURNER SYNDROME, related the webbing of the neck, loose skin and other anomalies of the syndrome to accumulation of fluid in the embryo starting at the head and dispersing to the extremities (as observed by Bonnevie in mice). Commonly observed at birth in Turner Syndrome and NOONAN SYNDROME; EDEMA of the extremities usually recedes by one year and is an early sign of Turner syndrome, especially in female neonates.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wemme, H1
Pohlenz, J1
Schönberger, W1

Other Studies

1 other study available for norethindrone acetate and Bonnevie-Ullrich Syndrome

ArticleYear
Effect of oestrogen/gestagen replacement therapy on liver enzymes in patients with Ullrich-Turner syndrome.
    European journal of pediatrics, 1995, Volume: 154, Issue:10

    Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Body Height; Child; Estrogen R

1995